masimo signal extraction technology for pulse oximetry....extraction of the data, step one, ? are they using the other two separations of v ip 744 patent family? is that patent family communicating via 8 's cpaas ip?:
Copilot
Certainly! Masimo Signal Extraction Technology® (SET®) is a groundbreaking pulse oximetry technology developed by Masimo Corporation. Let’s explore its key features and significance:
Background:
In 1989, engineers Joe Kiani and Mohamed Diab questioned why pulse oximetry didn’t work well during patient motion and low perfusion.
They set out to solve this problem, leading to the creation of Masimo SET®.
Challenges with Conventional Pulse Oximetry:
Conventional pulse oximetry had limitations during patient motion and low perfusion.
It assumed that only the pulsating component was arterial blood, leading to false alarms and inaccurate data.
Masimo SET® Approach:
Masimo SET® assumes that both arterial and venous blood can move.
It uses parallel signal processing engines (DST®, FST®, SST™, and MST™) to separate the arterial signal from noise sources (including venous signals).
This technology accurately measures oxygen saturation (SpO2) and pulse rate even during challenging conditions.
Clinical Benefits:
Unmatched Sensitivity and Specificity: Over 100 studies have shown that Masimo SET® outperforms other pulse oximetry technologies.
Reduced False Alarms: Clinicians can focus on critical patients with fewer false alarms.
Timely Detection: Early intervention for better patient outcomes and improved safety.
Applications:
Used in hospitals, home care, sports, and high-altitude environments.
Clinicians worldwide rely on Masimo SET® for accurate monitoring.
Revolutionizing Patient Monitoring:
Masimo SET® revolutionized pulse oximetry, providing reliable measurements even during challenging conditions.
It continues to enhance patient care and safety.
For more information, visit the Masimo SET® page. 🌟🩺
